Wait!!! A company with no product on the market that is currently going through costly pre-clinical trials is operating at a loss? NO KIDDING!!!! Investors understand that they are investing in the science and huge potential of PMCB and CiaB, not today's balance sheet.
News 
Market Data 
Discover 
